Cerebrospinal Fluid P-Tau(181P): Biomarker for Improved Differential Dementia Diagnosis

The goal of this study is to investigate the value of tau phosphorylated at threonine 181 (P-tau(181P)) in the Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker panel for differential dementia diagnosis in autopsy confirmed AD and non-AD patients. The study population consisted of 140 aut...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Struyfs, Hanne, Niemantsverdriet, Ellis, Goossens, Joery, Fransen, Erik, Martin, Jean-Jacques, De Deyn, Peter P., Engelborghs, Sebastiaan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2015
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4470274/
https://ncbi.nlm.nih.gov/pubmed/26136723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2015.00138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados